AbClon Inc
KOSDAQ:174900
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
AbClon Inc
Common Stock
AbClon Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
AbClon Inc
KOSDAQ:174900
|
Common Stock
₩10.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Common Stock
₩239.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Common Stock
₩39.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Common Stock
₩9.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Common Stock
₩26.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Common Stock
₩27.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
AbClon Inc
Glance View
AbClon, Inc. engages in the development, manufacture and sale of antibody drugs. The company is headquartered in Seoul, Seoul and currently employs 60 full-time employees. The company went IPO on 2017-09-18. The firm developed a bio synergy antibody, a therapeutic antibody for a new mechanism that is different from conventional therapeutic agents, and is based on the YPLUS and AffiMab platforms. The firm's products include AC101, AC103, AC104, AC106, AC203, AM201, AM101, AM102 and AM103. The firm distributes its products within domestic market and to overseas markets.
See Also
What is AbClon Inc's Common Stock?
Common Stock
10.2B
KRW
Based on the financial report for Dec 31, 2025, AbClon Inc's Common Stock amounts to 10.2B KRW.
What is AbClon Inc's Common Stock growth rate?
Common Stock CAGR 5Y
6%
Over the last year, the Common Stock growth was 12%. The average annual Common Stock growth rates for AbClon Inc have been 7% over the past three years , 6% over the past five years .
